There is a large pipeline of CAR-T cell therapies for diffuse large B-cell lymphoma
Chimeric antigen receptor T (CAR-T) cells are a form of ACT in which cells are engineered to express a synthetic…
By
Global
Latest in
Global
Alnylam identifies gene to lower abdominal fat and decrease cardiovascular risk
Alnylam aims to develop a therapy that targets the INHBE gene and reduces the overall risk of T2D and coronary…
By
Partner content
CMO checklist: Selecting a partner that’s right for you
Working with a contract manufacturing organization (CMO) in the pursuit of bringing a new product to market can deliver a…
No drugs for prions: could new approaches alleviate therapeutic scarcity?
An incomplete understanding of the disease, low incidence, and a rapid progression hamper the development of therapies for TSEs.
By
How close are we to getting a male contraceptive?
With public demand for new options, the male contraceptive research field is advancing despite persistent challenges.
By
Implementation of electronic health records will improve the quality of care
Electronic health records (EHRs) are expected to drive big changes in the provision of healthcare and clinical research delivery.
By
Governments and pharma relationships and implications for antimicrobial resistance
To overcome the growing threat posed by antimicrobial resistance, a variety of approaches must be taken.
By
Schizophrenia trials continue to test drug candidates as Covid-19 pandemic continues
A total of 127 planned schizophrenia clinical trials are planned to be held over the coming years.
By